Medical Necessity Criteria for Attention Deficit Hyperactivity Disorder (ADHD) Agents
All current and new users of nonformulary ADHD agents must meet one of the following criteria in order for
medical necessity to be approved:
1.
Use of ALL of the following formulary alternatives is contraindicated (e.g., due to hypersensitivity): extended
release methylphenidate (e.g., Concerta, Metadate CD, and Ritalin LA) and extended release mixed amphetamine
salts (Adderall XR).
2.
The patient has experienced or is likely to experience significant adverse effects from ALL of the following
formulary alternatives: extended release methylphenidate (e.g., Concerta, Metadate CD, and Ritalin LA) and
extended release mixed amphetamine salts (Adderall XR).
3.
Use of ALL of the following formulary alternatives has resulted in therapeutic failure: extended release
methylphenidate (e.g., Concerta, Metadate CD, and Ritalin LA) and extended release mixed amphetamine salts
(Adderall XR).
4.
(Daytrana patch only) - The patient is unable to take oral medications.
Medical necessity criteria for Daytrana, Focalin, and Focalin XR recommended by the DoD Pharmacy &
Therapeutics Committee at the Nov 2006 meeting & approved by the Director, TMA on 17 Jan 2007. Medical
necessity criteria for Vyvanse recommended by the DoD Pharmacy & Therapeutics Committee at the Nov 2007
meeting & approved by the Director, TMA on 13 February 2008. For more information, please see the
DoD P&T
Committee
minutes..
is the official Web site of the
TRICARE Management Activity,
a component of the
Military Health System
Skyline 5, Suite 810, 5111 Leesburg Pike,
Falls Church, VA 22041-3206